BriaCell Therapeutics's total assets for Q2 2026 were C$33.31M, an increase of 154.79% from the previous quarter. TSE:BCT total liabilities were C$3.35M for the fiscal quarter, a -9.99% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.